Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 38Neoplasms 22Motor Activity 12Colorectal Neoplasms 9Lung Neoplasms 8Stomach Neoplasms 7Pain, Postoperative 7Fatigue 7Anxiety Disorders 6Pain 5Carcinoma, Hepatocellular 5Rectal Neoplasms 4Polycystic Ovary Syndrome 4Leukemia, Myeloid, Acute 4Depression 4Colonic Neoplasms 4Thyroid Neoplasms 3Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malnutrition 3Liver Neoplasms 3Head and Neck Neoplasms 3Agnosia 3Vomiting 2Uterine Cervical Neoplasms 2Urinary Incontinence 2

Interventions

Propofol 4Saline Solution 3Dexmedetomidine 3remimazolam 2Sugammadex 1Sufentanil 1Sodium Chloride 1Ropivacaine 1Pyridostigmine Bromide 1Neuroleptanalgesia 1Nalbuphine 1Minocycline 1Midazolam 1Methylene Blue 1Ketamine 1Injections 1Ibuprofen 1Duloxetine Hydrochloride 1Control Groups 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Emergence Delirium × Control Groups × Clear all
NCT07627906 2026-06-04

Ketofol Versus Ketodex for POD Prophylaxis in Elderly Cancer Surgery

Cairo University

Phase 3 Recruiting
180 enrolled

Emergence Delirium, Postoperative Cognitive Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡